The U.S. healthcare industry is undergoing a significant transformation as a few large insurance corporations increasingly assert their dominance. The American Medical Association's recent report, "Competition in Health Insurance: A Comprehensive Study of U.S. Markets," paints a concerning picture
Series A Success A Rapid Sequence of Funding Rounds Coverdash, an insurtech startup based in New York, has recently garnered significant investor attention by securing a $13.5 million Series A funding round. This new capital infusion adds to its already impressive fundraising achievements, bringing
The health of the US commercial insurance sector is reflected through the pattern of policy pricing changes. Recent data from WTW's Commercial Lines Insurance Pricing Survey (CLIPS) for Q4 2023 highlights a significant rise in prices, now exceeding 6%, which marks a clear increase compared to
The insurance landscape in California is experiencing significant changes as Farmers Direct Property and Casualty Insurance exits the market, affecting around 100,000 policyholders. This departure hints at the company's redirected strategy, possibly due to the intricate regulatory demands and the
The Invesco KBW Property & Casualty Insurance ETF (KBWP) stands out in the investment world, catering to those interested in the dynamic financial sector. This ETF focuses specifically on the property and casualty insurance industry, offering investors a targeted entry point into an essential part
In the fiscal landscape of 2024, life insurance remains a cornerstone of prudent financial planning. Not only does it provide assurance for the unforeseeable future, but it also offers a safety net to dependents left behind. The methodology behind identifying the frontrunners in the life insurance
Annuities can be a cornerstone of retirement planning, providing a steady income for retirees. The intricacies of annuities and their lifelong implications mean that choosing a trustworthy provider is critical. As we head toward 2024, evaluating which companies can deliver not just financial
The Biden-Harris Administration is calling upon Congress to extend the benefits of the Inflation Reduction Act beyond its current parameters to further reduce prescription drug costs for Americans with commercial insurance. This initiative builds on the Act's existing measures that have already
